Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer

BACKGROUND: With the identification of new targetable drivers and the recent emergence of novel targeted drugs, using comprehensive genomic profiling in lieu of the routine testing for classic drivers in the clinical care for advanced NSCLC has been increasingly advocated. However, the key assumptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shen, Zhang, Zhonghan, Zhan, Jianhua, Zhao, Xin, Chen, Xinru, Xiao, Liyun, Wu, Kui, Ma, Yuxiang, Li, Mengzhen, Yang, Yunpeng, Fang, Wenfeng, Zhao, Hongyun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485523/
https://www.ncbi.nlm.nih.gov/pubmed/34592968
http://dx.doi.org/10.1186/s12916-021-02089-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485523/
https://www.ncbi.nlm.nih.gov/pubmed/34592968
http://dx.doi.org/10.1186/s12916-021-02089-z

Ejemplares similares